U.S. Markets close in 4 hrs 22 mins

Allergan’s Stock Performance and Estimates for Q3 2018

Mike Benson
Allergan’s Stock Performance and Estimates for Q3 2018

Allergan’s (AGN) product portfolio includes generic pharmaceutical products and specialty pharmaceutical products. The company’s business comprises three segments—US General Medicines, US Specialized Therapeutics, and International. The chart below compares Allergan’s revenues and EPS since the first quarter of 2017, as well as its estimates for the third quarter.